|
Originally published In Press as doi:10.1074/jbc.M110506200 on January 8, 2002
J. Biol. Chem., Vol. 277, Issue 12, 9853-9864, March 22, 2002
Cytochrome P450 2E1-derived Reactive Oxygen Species Mediate
Paracrine Stimulation of Collagen I Protein Synthesis by Hepatic
Stellate Cells*
Natalia
Nieto ,
Scott L.
Friedman§, and
Arthur I.
Cederbaum ¶
From the Department of Pharmacology and Biological
Chemistry and the § Department of Medicine and Liver
Diseases, Mount Sinai School of Medicine,
New York, New York 10029
Received for publication, November 1, 2001, and in revised form, December 18, 2001
 |
ABSTRACT |
To evaluate possible fibrogenic effects of
CYP2E1-dependent generation of reactive oxygen species, a
model was developed using co-cultures of HepG2 cells, which do (E47
cells) or do not (C34 cells) express cytochrome P450 2E1 (CYP2E1) with
stellate cells. There was an increase in intra- and extracellular
H2O2, lipid peroxidation, and collagen
type I protein in stellate cells co-cultured with E47 cells compared
with stellate cells alone or co-cultured with C34 cells. The increase
in collagen was prevented by antioxidants and a CYP2E1 inhibitor.
CYP3A4 did not mimic the stimulatory effects found with CYP2E1.
Collagen mRNA levels remained unchanged, and pulse-chase analysis
indicated similar half-lives of collagen I protein between both
co-cultures. However, collagen protein synthesis was increased in E47
co-culture. Hepatocytes from pyrazole-treated rats (with high levels of
CYP2E1) induced collagen protein in primary stellate cells, and
antioxidants and CYP2E1 inhibitors blocked this effect. These results
suggest that increased translation of collagen mRNA by
CYP2E1-derived reactive oxygen species is responsible for the increase
in collagen protein produced by the E47 co-culture. These co-culture
models may be useful for understanding the impact of CYP2E1-derived ROS
on stellate cell function and activation.
 |
INTRODUCTION |
Hepatic fibrosis is a common response to chronic liver injury,
regardless of its nature (viral infection, alcohol abuse, and metal
overload) and is also characterized by excessive deposition of
extracellular matrix components (1). Oxidative stress represents a
common link between the different types of chronic liver injury including iron overload (2, 3), ethanol (4, 5), CCl4 (6),
and hepatitis C virus (7). In exploring the role of oxidative stress,
it can be difficult to discriminate between the indirect effect of
necrosis on stimulating fibrosis and a direct fibrogenic effect of free
radical species. However, it is increasingly clear that in addition to
an effect of necrosis, there is a direct stimulation of extracellular
matrix deposition during the prenecrotic stage of liver injury (8). The
mechanisms underlying the fibrogenic effects of oxidative stress are
not clarified. In particular, does oxidative stress provoke release of
fibrogenic mediators by hepatocytes, directly stimulate fibrogenesis, or both?
Hepatic stellate cells (HSC)1
are the primary fibrogenic cell type in liver (9). During liver injury,
they become activated, developing a myofibroblast-like phenotype
associated with increased proliferation and collagen synthesis (1).
In vivo, fibrosis is associated with free radical production
in hepatocytes located near HSC, either in iron overload-induced (3,
10) or in CCl4-induced liver injury (11). In fact, when
iron overload is localized only in reticuloendothelial cells, no
activation of collagen gene expression can be detected (2).
Svegliati-Baroni et al. (8) have demonstrated that
conditioned medium from hepatocytes activates the
Na+/H+ exchanger and stimulates HSC
proliferation, and the effect is reversed by the
Na+/H+ exchange inhibitor, amiloride. These
findings suggest that the Na+/H+ exchanger
could represent a common mediator of the different effects induced by
oxidative stress on HSC such as proliferation and increased collagen
type I. These data further suggest that paracrine signals from
hepatocytes may stimulate HSC proliferation and collagen synthesis
in vivo.
Cytochrome P450 2E1 (CYP2E1) has assumed an important role in
alcohol-induced oxidative stress and liver injury. In the intragastric model of ethanol feeding, there is prominent induction of CYP2E1, a
large increase in lipid peroxidation, and significant alcoholic liver
injury in rats fed diets containing polyunsaturated fatty acids but not
saturated fatty acids (6, 12, 13), and inhibitors of CYP2E1 block these
responses (14). In a recently established HSC line overexpressing
CYP2E1, there was an increase in collagen production by a mechanism
dependent upon CYP2E1-derived intracellular ROS (15, 16). In
vivo, however, most CYP2E1 in the liver is localized in the
hepatocyte, and there is little information about potential paracrine
stimulation by hepatocyte-derived ROS of HSC fibrogenesis, either
in vivo or in culture.
The aim of this study was to develop a co-culture model in order to
evaluate how CYP2E1-dependent generation of ROS impacts activation of HSC, their antioxidant defense system, and extracellular matrix production. The model is based on the co-incubation of the
previously established HepG2 cell lines, which do (E47 cells) or
do not (C34 cells) express the human CYP2E1 (17, 18), with an
immortalized rat HSC line. Some experiments were carried out using
primary hepatocytes from either control or pyrazole-treated rats, in
which there is an increase in CYP2E1 expression, co-cultured with
freshly isolated HSC. These co-culture systems would more closely
resemble the in vivo situation, where cell-to-cell
communication may play a critical role in provoking fibrosis.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Most reagents, unless specified, were from Sigma.
2',7'-dichlorofluorescein diacetate and cis-parinaric acid
were from Molecular Probes, Inc. (Eugene, OR).
Cell Culture--
The model used in most of the experiments
described below is based on the co-culture of HepG2 cell lines that
either do (E47 cells) or do not (C34 cells) express the human CYP2E1
(17, 18) with an immortalized rat stellate cell line (T6-HSC) (Fig. 1) (19, 20). The T6-HSC contain intracellular filaments typical of primary
HSC, express desmin, -smooth muscle actin, vimentin and glial
fibrillary acidic protein, take up and esterify retinol and
retinol-binding protein, and are otherwise similar to primary stellate
cells (19). Catalytic activity of CYP2E1 in the E47 cells was monitored
by the oxidation of p-nitrophenol to
p-nitrocatechol prior to each experiment (21). To extend the
results with the above cell lines to normal hepatic tissue, selected
experiments were carried out using freshly isolated rat HSC co-cultured
with rat hepatocytes. Hepatocytes were isolated from saline-treated or
pyrazole-treated rats (200 mg/kg of body weight/day for 2 days, followed by an overnight fast) as described by Wu and Cedarbaum (22).
Pyrazole was used to elevate the level of CYP2E1 in the hepatocytes,
whose content and activity was measured at the beginning and at the end
of the experiments. Primary HSC were isolated from male Sprague-Dawley
rats (600 ± 25 g) (Charles River Laboratories, Wilmington,
MA) by in situ liver perfusion with bacterial pronase and
collagenase followed by density gradient centrifugation with Nycodenz
according to published protocols (23). Cell viability (95%) was
assessed by the trypan blue exclusion method. Purity of the HSC (97%)
was determined as described previously (23). Cells were co-cultured
using cell culture inserts (3-µm pore size) to separate both cell
populations; the HSC are plated on the bottom, and the HepG2 cells or
hepatocytes are plated on the insert to create a gravity
gradient of the released mediators. A ratio of HepG2 (or
hepatocytes)/HSC of 5:1 was chosen, since it is representative of the
ratio of parenchymal/nonparenchymal cells in liver (24). After
overnight incubation of HSC alone in MEM supplemented with 10% fetal
bovine serum and essential amino acids, the HSC medium was discarded,
the cell culture inserts containing the overnight incubated C34 or E47
cells were transferred, and the medium from the C34 or E47 cells was
added to the co-culture systems. At this time, all additions were made
(t = 0 h). In experiments using hepatocytes, they
were directly plated on top of the freshly isolated HSC. For
experiments in which conditioned medium was used, C34 or E47 cells were
grown in flasks until 90% confluence without replacing the medium,
typically 5 days; the medium was collected, centrifuged, and filtered
through a 0.2-µm syringe filter before it was added to the HSC.
General Methodology--
Plasmid DNA preparation as well as
transfection procedures, Northern and Western blot analysis,
intracellular production of ROS (including H2O2
using dichlorodihydrofluorescein and intracellular lipid peroxidation
products using cis-parinaric acid), the activities of
antioxidant enzymes, GSH levels, and cell viability assays are
described in previous publications (15, 16, 23).
H2O2 concentration as well as lipid
peroxidation products in the culture medium without phenol red were
assayed by the FOX method (25) and by the TBARS assay (26),
respectively. The probes used for Northern blot were a cDNA clone
Hf1131 coding for COL1A2 (27), COL1A1, MMP-13, TIMP-1 (provided by Drs.
Scott Friedman (Mount Sinai School of Medicine), Detlef Schuppan
(Universität Erlangen-Murnberg), and Marcos Rojkind (Albert
Einstein College of Medicine), respectively), and a S14
ribosomal protein cDNA clone purchased from the American Type Culture Collection (Manassas, VA). Quantitative comparison of the
intensity of the signal scanned in a PhosphorImager (Molecular Dynamics, Inc., Sunnyvale, CA) was performed using the ImageQuant software. Western blots were done on cell lysates or with 10-fold concentrated incubation media passed through centricon columns (molecular mass cut-off of 50 kDa) using antibodies raised
against collagen type I (1:5000; provided by Dr. Detlef Schuppan,
Universität Erlangen-Murnberg), MMP-13 (1:1000; provided by Dr.
John Jeffrey (Albany Medical School)), TIMP-1 (1:1000; Chemicon),
CYP2E1 (1:30.000; provided by Dr. Jerome Lasker (Mount Sinai School of
Medicine)), and catalase (1:2000; Calbiochem). Goat anti-rabbit IgG
conjugated to horseradish peroxidase was used as second antibody
(1:5000; Chemicon).
Collagen Type I Protein Synthesis and Degradation--
HSC and
HepG2 control (C34) or CYP2E1-expressing cells (E47) were plated
separately in 10% fetal bovine serum-MEM; after overnight incubation,
the medium from the HSC was removed, and the inserts containing the C34
or E47 cells together with their culture medium were transferred onto
the plates containing the HSC; fresh medium was also added to the HSC
that were plated with an empty insert as a reference group (not to be
co-cultured with HepG2 cells). 22 h later, the media from the
complete co-culture systems were replaced with methionine-cysteine-free
MEM plus 10% dialyzed fetal bovine serum, and the cells were incubated
for 2 h, after which they were pulse-labeled with 150 µCi of
EasyTagTM EXPRE35S35S Protein
Labeling Mix (PerkinElmer Life Sciences) for 0, 1, 2, 4, 8, and 12 h to study the rate of collagen synthesis. A set of samples was pulsed
for 2 h in the presence of 40 µM cycloheximide, an
inhibitor of protein synthesis, as a control for the analysis of
collagen synthesis. Following the pulse, the cells were washed in 1×
phosphate-buffered saline and lysed at the indicated time points with
150 µl of 10 mM Tris-HCl buffer, pH 7.4, 0.5% Triton X-100, 1 mM EDTA, 150 mM NaCl, 0.5% sodium
deoxycholate, 1% SDS, and 1 mM phenylmethylsulfonyl fluoride.
To study the rate of collagen degradation, the co-cultures were treated
as above but pulse-labeled with the EXPRE35S35S
mix for 24 h. The cells were then washed three times and chased with complete MEM supplemented with 300 µg/ml of cold methionine. Cells were washed in 1× phosphate-buffered saline and lysed at chase
times of 0, 1, 2, 4, 8, and 12 h in the same lysis buffer. In all
cases, collagen I was immunoprecipitated with anti-rat-collagen I
IgG-protein G-agarose as follows: 40 µl of cell lysate were first
incubated with 10 µl of preimmune rabbit serum for 15 min, followed
by the addition of 30 µl of a 50% (v/v) suspension of protein
G-agarose. After centrifugation for 2 min at 13,000 rpm, the
supernatant was incubated with anti-rat collagen I IgG rocking overnight at 4 °C followed by the addition of 30 µl of a
suspension of protein G-agarose. Samples were centrifuged for 1 min at
13,000 rpm, and the pellets were washed three times with lysis buffer, once with lysis buffer plus 2% SDS, and three times with 0.1 M Tris-HCl buffer, pH 6.8. Collagen I was eluted by boiling
for 5 min in Laemmli's buffer, and samples were centrifuged for 2 min
at 13,000 rpm to remove the protein G-agarose, resolved on a 5%
SDS-PAGE, and dried. The intensity of the radioactive signal was
quantified using the PhosphorImager and the ImageQuant software.
To evaluate the rate of total protein synthesis by HSC, cells were
treated as above and pulsed for 0, 1, 2, 4, 8, and 12 h, followed
by the addition of 30% trichloroacetic acid to stop the reaction. The
cells were washed in 1× phosphate-buffered saline, and the
trichloroacetic acid-precipitable counts were determined in a
scintillation counter after resuspension of the pellets in scintillation liquid. To evaluate the rate of HSC total protein degradation, the co-cultures were pulse-labeled for 24 h as above, followed by chasing for 0, 1, 2, 4, 8, and 12 h. The HSC were treated with 30% trichloroacetic acid and washed, and the
trichloroacetic acid-precipitated counts were determined as described above.
Statistics--
Results represent mean ± S.E. and are
average values from three experiments that were repeated at least
twice. Comparisons among groups were made using Student's t test.
Nomenclature--
With the exception of results in Fig. 10, which utilized freshly isolated rat HSC, the T6-HSC line was used in
all other experiments. The designation HSC refers to data found in the HSC incubated with an empty insert; HSC/C34 refers to results obtained in the HSC after co-culture with the C34
cells, and HSC/E47 refers to results obtained in the HSC
after co-culture with the E47 cells. Similarly, the designations
HSC/C34 and HSC/E47 refer to data obtained in the C34 and E47 cells after co-culture with the HSC, while
C34 and E47 refer to results for the C34 and
E47 cells incubated alone.
 |
RESULTS |
Characterization of the Co-culture Model--
Indirect evidence
suggests a paracrine mechanism by which hepatocytes stimulate HSC
proliferation and collagen synthesis in vivo (3, 10). HepG2
cells, which do (E47 cells) or do not (C34 cells) overexpress CYP2E1,
were incubated in the presence of HSC using a dual chamber apparatus
that separates the cell types but allows for rapid exchange of soluble
mediators (Fig. 1). Cells were plated at
a ratio of HepG2 cells (or hepatocytes)/HSC of 5:1 (24). HSC were
cultured alone for 16 h, after which the medium was discarded;
then the cell culture inserts containing either HepG2 cells or
hepatocytes (or no cells) were transferred together with the culture
medium to the plates containing the HSC; this defined the beginning of
the co-culture period (t = 0 h). Samples of either
cell lysate from HSC or culture medium were then collected at different
time points. Preliminary experiments were performed mixing both cell
types directly to determine if cell-cell contact was necessary to
stimulate collagen production; effects were identical to those
described below for the dual chamber model. Therefore, the latter
system was used exclusively, because the experiments allowed 1)
determination of whether ROS diffuse and enter stellate cells, 2)
examination of the antioxidant defense of the HSC, and 3) assessment of
rates of total protein synthesis and degradation. This approach was
essential to collect RNA and cell extracts only from the stellate cells
and avoid a dilution error due to small differences in cell growth of
any of the cell populations.

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 1.
Scheme of the co-culture model. HSC were
seeded on the bottom plate at a density of 2.5 × 105
cells in 3 ml of culture medium. CYP2E1 activity was measured by the
p-nitrophenol oxidation method and 1.25 × 106 C34 or E47 cells were plated on the insert in 3 ml of
culture medium. After overnight incubation (16 h), the medium from the
HSC was discarded, and the inserts were transferred together with the
incubation medium from the C34 and E47 cells onto the HSC. New medium
was added to HSC plated with empty inserts; these were considered as
non-co-cultured controls. Various additions were made at this time
(t = 0 h), and samples of either HSC or HepG2
cells or medium were collected at different time points. Selected
experiments were carried out with freshly isolated rat HSC and primary
hepatocytes from either saline- or pyrazole-treated rats.
|
|
Antioxidant Status of the Co-cultures--
The antioxidant status
of the HSC alone and following co-culture with either C34 or E47 cells
(HSC, HSC/C34, and HSC/E47, respectively) was characterized in order to evaluate whether the effect
of CYP2E1-derived oxidative stress on HSC activation is amplified by
impaired antioxidant defense. The levels of antioxidants in the HSC
were considerably lower than those in HepG2 cells. Incubation of HSC
with either C34 or E47 cells did not affect their activity of
glutathione transferase, glutathione reductase, GPX, SOD, catalase, or
GSH levels (Table I). Thus, no
significant changes in the antioxidant defense were observed in the
co-cultured HSC. The basal expression of glutathione transferase,
glutathione reductase, catalase, and GSH but not GPX or SOD
increased in the E47 cells when compared with the
C34 cells (p < 0.01) as previously described (28), suggesting that HepG2 cells up-regulate antioxidant defense in response to CYP2E1 production of ROS via increased metabolism of H2O2 and elevated GSH levels.
View this table:
[in this window]
[in a new window]
|
Table I
Antioxidant defense in the co-culture models
The activities of glutathione transferase (GT), glutathione reductase
(GR), GPX, CAT, and SOD, and GSH levels were measured in the HSC alone
or co-cultured with C34 or E47 cells for 24 h as well as in C34
and E47 cells cultured alone. Results are expressed in units/mg of
protein for the enzymes and in nmol/mg of protein for GSH and reflect
mean ± S.E. (n = 3). ***, p < 0.001 compared with C34 cells.
|
|
Generation of ROS--
Since ROS such as
H2O2 could mediate the effects of CYP2E1 on
HSC, the intracellular concentration of ROS species such as H2O2 in each cellular component of the
co-cultures was measured. Co-incubation of E47 cells with HSC increased
DCF fluorescence in the HSC by 35% (p < 0.01) as
compared with HSC incubated alone or co-cultured with the C34 cells
(Fig. 2A). There was a 3-fold increase in ROS levels in the E47 cells when compared with the C34
cells (p < 0.01) (Fig. 2A), validating the
ability of CYP2E1 to actively catalyze ROS production even in the
presence of an enhanced antioxidant defense. This increase in ROS by
E47 cells was not altered by co-culture with the HSC (compare
E47 and HSC/E47). To determine whether there is
a gradient/efflux of H2O2 from the E47 to the
HSC that could explain the increase in HSC intracellular H2O2 in the HSC/E47 co-culture, we measured
H2O2 concentration in the incubation medium and
found a 40% increase in the HSC/E47 co-culture as compared with HSC
incubated alone or HSC co-cultured with C34 cells (p < 0.01) (Fig. 2B). To confirm that effects were due to
H2O2, 5 µM commercial
H2O2 was added as a positive control. The
addition of catalase to the incubation medium or transfecting with
catalase (pZeo-CAT) lowered the levels of endogenous
H2O2 or exogenous added
H2O2. Note that since the E47 cells have higher activity of catalase, glutathione transferase, and GSH than the C34
cells (28), the addition of commercial H2O2 to
the HSC/E47 co-culture resulted in greater metabolism of the added
H2O2. These data suggest that some of the
elevated H2O2 generated by the E47 cells
increases the intracellular concentration of
H2O2 in the HSC following its diffusion.

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 2.
ROS production in the co-cultures.
A, the concentration of ROS, mainly
H2O2, in each cell line used in the co-cultures
after 24 h of incubation was assayed by flow cytometry using the
2',7'-dichlorofluorescein diacetate method. Results are expressed as
units of fluorescence and refer to mean ± S.E. (n = 3). **, p < 0.005 compared with HSC and
HSC/C34. B, the concentration of
H2O2 in the incubation medium at 24 h was
assayed by the FOX method. Controls included 2000 units of catalase,
transfected catalase (pZeo-CAT), 5 µM
H2O2, and the combination of transfected
catalase and 5 µM H2O2. Results
are expressed as µM H2O2 and
refer to mean ± S.E. (n = 3). **,
p < 0.005 compared with HSC or
HSC/C34. In all cases, the effects of catalase, transfected
catalase, H2O2, and transfected catalase plus
H2O2 were significantly different
(p < 0.005 or p < 0.001) than the no
addition control (first bar graph of
each group).
|
|
Increased Lipid Peroxidation--
In addition to
H2O2, lipid peroxidation-derived products are
another possible mediator for the effects of CYP2E1 on HSC. Therefore, lipid peroxidation in each cell type within the co-cultures was measured using the cis-parinaric acid method (decreased
fluorescence reflects increased lipid peroxidation). Increased
peroxidation was observed in the HSC/E47 co-culture compared with HSC alone or co-cultured with C34 cells
(p < 0.01, Fig.
3A). As expected, lipid
peroxidation was increased in the E47 cells compared with the C34
cells, and this increase was not affected by co-culture with the HSC
(E47 or HSC/E47 compared with C34
or HSC/C34) (Fig. 3A). Moreover, when lipid
peroxidation-derived products in the incubation medium were measured,
there was a 40% increase in TBARS in the HSC/E47 co-culture when
compared with the HSC incubated alone or the HSC/C34 co-culture
(p < 0.01) (Fig. 3B). Cells were also
incubated in the presence of 45 µM arachidonic acid as a
positive control in the presence or absence of 25 µM
vitamin E. Arachidonic acid increased TBARS production especially in
the co-cultures containing the E47 cells, and vitamin E prevented this
increase. These results suggest that both H2O2
and lipid peroxidation products are increased in the HSC themselves and
the incubation medium after co-culturing with CYP2E1-containing cells.
We believe that the H2O2 and lipid peroxidation
products are largely derived from the E47 cells, since the increase of
these ROS was blocked by added catalase and vitamin E, analogous to the
prevention of increased collagen type I protein (described below).
However, the possibility that the E47-derived oxidative stress can
elevate ROS by the HSC cells themselves cannot be ruled out, so that
several possibilities contribute to the enhanced state of oxidative
stress in the HSC/E47 co-culture.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 3.
Lipid peroxidation production in the
co-cultures. A, the formation of lipid peroxidation
products in each cell line used in the co-cultures after 24 h of
incubation was assayed by the cis-parinaric acid method.
Results are expressed as units of fluorescence and refer to mean ± S.E. (n = 3). **, p < 0.005 compared with HSC or HSC/C34. B,
lipid peroxidation products in the incubation medium at 24 h were
determined by the TBARS method. Controls included 45 µM
of arachidonic acid in the presence or absence of 25 µM
vitamin E. Results are expressed as nM TBARS and refer to
mean ± S.E. (n = 3). **, p < 0.005 compared with HSC or HSC/C34. In all groups, the increase in
TBARS produced by arachidonic acid and the prevention by vitamin E of
this increase was significant (p < 0.005 or
p < 0.001) compared with the nonaddition
control.
|
|
CYP2E1-derived Mediators Increase Collagen I Protein but Not COL1A2
mRNA--
Incubation of HSC with conditioned medium from the C34
cells grown in flasks for 5 days had no effect on the levels of
collagen type I protein or COL1A2 mRNA levels (data not shown).
However, there was a 4-fold increase in collagen type I protein
expression in the HSC co-cultured with the E47 cells. This increase in
collagen I protein was not associated with a corresponding change in
the COL1A2 mRNA levels (not shown). Thus, these initial experiments validated the concept that the CYP2E1-expressing HepG2 cells released mediators, which could promote increased collagen type I protein in
HSC. To study this further, subsequent experiments utilized the
co-culture model.
HSC Collagen I Protein Is Increased When Co-cultured with E47
Cells--
HSC were co-cultured with either the C34 or E47 cells in
the presence or absence of 0.1 mM L-buthionine
sulfoximine, an irreversible inhibitor of -glutamylcysteine
synthetase, which depletes GSH levels. HSC lysates, and aliquots of the
incubation medium were collected at 3, 6, 12, and 24 h and
analyzed by Western blot for collagen I. A time-dependent
increase in collagen production was observed, which was more pronounced
at 12 and 24 h in the E47 co-culture than in the C34 co-culture
(data not shown). This effect was slightly increased by treatment with
L-buthionine sulfoximine at the more prolonged incubation
time of 24 h. Fig. 4 shows the 24-h
co-culture data; there was enhanced type I collagen in co-cultures with
E47 cells in the absence or presence of L-buthionine
sulfoximine compared with the HSC co-cultured with C34 cells. Moreover,
there was an increase in secretion of collagen I to the medium of the E47 co-culture as assessed by Western blot, which was also potentiated by L-buthionine sulfoximine (Fig. 4). To ensure that the
increase in collagen I protein in HSC by co-culture with E47 cells and treatment with L-buthionine sulfoximine was not a general
effect on HSC protein synthesis, the expression of catalase in the
samples collected at 24 h was also determined; no change was
detected (Fig. 4). However, under these conditions, co-culture of HSC
with either C34 or E47 cells, in the absence or presence of 0.1 mM L-buthionine sulfoximine (BSO), did
not alter the expression of COL1A1 or COL1A2 mRNA or the ratio of
COL1A1 or COL1A2 to the housekeeping S14 ribosomal protein mRNA
(data not shown). This suggests that the stimulating effect of the E47
co-culture system on collagen I protein is not regulated at the
mRNA level, results similar to those obtained with the conditioned
medium experiments described above.

View larger version (54K):
[in this window]
[in a new window]
|
Fig. 4.
Collagen I protein is increased in the
HSC/E47 co-culture system. The HSC/C34 or HSC/E47 co-cultures were
incubated in the presence or absence of 0.1 mM
L-buthionine sulfoximine for 24 h, and levels of the
indicated proteins in HSC lysates were analyzed by Western blot. Levels
of collagen I and MMP-13 secreted to the incubation medium were also
evaluated. Numbers under the blots
refer to arbitrary densitometric units.
|
|
Since changes in collagen I protein may occur in association with
altered collagenase activity, the expression of MMP-13 and TIMP-1 was
determined by Western blot. The expression of MMP-13 and TIMP-1 protein
in the HSC and in the extracellular medium remained unchanged at the
different time points selected (data not shown) and was not altered by
either co-culture with E47 cells compared with C34 cells or by
L-buthionine sulfoximine treatment (Fig. 4). Taken
together, these data suggest that the increase by the E47 co-culture on
collagen I protein levels is not due to changes in the expression of
major proteases such as MMP-13 or its inhibitors. Experiments to
determine the rate of collagen synthesis and degradation in both
co-culture systems are described below.
Comparison between the Effect of CYP2E1- and
CYP3A4-derived Diffusible Mediators on Collagen I Protein in the
Co-culture Model--
The C34 cells do not have significant amounts of
cytochrome P450; therefore, it is not clear whether the increase in
collagen I protein by the E47 co-culture is due to the presence of
CYP2E1 or to the presence of any other P450. We therefore evaluated
whether CYP3A4, another enzyme of the P450 family, produces the same
effect as CYP2E1 on collagen I protein. HSC were co-cultured with C34, E47, or HepG2 cells overexpressing CYP3A4 (kindly provided by Dr. Denis
Feierman, Mount Sinai School of Medicine) for 24 h and evaluated
for collagen I expression by Western blot. The HSC/CYP3A4 co-culture
produced a 2-fold increase in collagen I protein over the basal
expression found in the HSC/C34 co-culture, whereas the HSC/E47 system
produced a 8-fold increase in collagen over the basal HSC/C34
co-culture (Fig. 5). Thus, CYP2E1 was
more effective than CYP3A4 in mediating paracrine stimulation of
collagen type I protein levels in stellate cells.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 5.
Comparison between CYP2E1- and
CYP3A4-mediated induction of collagen I protein. HSC were
co-cultured with C34, E47, or HepG2 cells overexpressing CYP3A4 for
24 h. 10 µg of HSC extract were resolved on a 5%
SDS-polyacrylamide gel followed by Western blot using rabbit monoclonal
anti-collagen I antibody. The HSC/CYP3A4 co-culture had a 2-fold
increase in collagen I protein over the basal expression found in the
HSC/C34 co-culture as compared with a 8-fold increase produced by the
HSC/E47 system.
|
|
Antioxidants Prevent the CYP2E1-mediated Increase in
Collagen I Protein--
Since there was an increase in
H2O2 and lipid peroxidation in HSC co-cultured
with the E47 cells, the inhibitory effect of antioxidants or a CYP2E1
inhibitor on collagen type I was assessed. Cells were plated and grown
overnight; the next morning, the inserts and the incubation medium from
the C34 or E47 cells were transferred onto the HSC and the co-cultures
were immediately treated with either a 1 mM concentration
of the CYP2E1 inhibitor diallylsulfide, 2000 units of catalase, 25 µM vitamin E, or 2 mM glutathione ethyl ester
or transfected with the empty vectors pZeo or pcDNA3 or with the
expression vectors containing the cDNAs encoding for catalase
(pZeo-CAT), GPX (pZeo-GPX), and Mn-SOD (pcDNA3-SOD). The co-cultures
were maintained in the presence of these chemicals or
transfection mix for 24 h, and cell lysates from the HSC were collected and analyzed by Western blot. Collagen I protein was almost
4-fold higher with the HSC/E47 than with the HSC/C34 co-culture (Fig.
6). Transfection with control plasmids
did not affect the basal expression of collagen in any of the
co-cultures. Diallylsulfide had no effect with the C34 co-cultures but
prevented the increase in collagen I protein in the HSC/E47 co-culture,
validating the role of CYP2E1. Added catalase, which metabolizes
H2O2, completely prevented the increase by
CYP2E1-derived mediators on collagen; it also decreased the basal
expression of collagen I, indicating that endogenous
H2O2 may have a parallel impact on endogenous collagen protein synthesis. Vitamin E, which prevents lipid
peroxidation, had no effect on collagen levels in the C34 co-culture
but completely prevented the increase in collagen I in the HSC/E47
system, suggesting that lipid peroxidation-derived products may be key
mediators in the CYP2E1-dependent increase. Glutathione
ethyl esther, a cell-permeable precursor of GSH, had no effect with the
C34 co-culture but inhibited the increase by CYP2E1-derived diffusible
mediators on collagen protein by 40% in the HSC/E47 system.
Transfections with pZeo-CAT, pZeo-GPX, and pcDNA3-SOD completely
blocked collagen protein levels in the E47 co-culture, suggesting a
role for ROS in the increase produced by the E47 cell co-culture.
Interestingly, these transfections blocked also the collagen expression
in the C34 co-culture, suggesting that the basal production of collagen type I protein is regulated, at least in part, by endogenous ROS. Taken
together, these data suggest that CYP2E1 plays a role in the enhanced
collagen I protein expression in the E47 co-culture by increasing
production of ROS such as H2O2 and lipid
peroxidation products. Western blot analysis as well as assays of
the oxidation of p-nitrophenol showed that none of these
treatments affected significantly the basal expression or activity of
CYP2E1 except for diallylsulfide, which as expected, inhibited
CYP2E1-dependent oxidation of p-nitrophenol.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 6.
Antioxidants prevent CYP2E1-mediated increase
of collagen I protein. The HSC/C34 or HSC/E47 co-cultures were
pretreated with 1 mM diallylsulfide (DAS), 2000 units of catalase, 25 µM vitamin E, 2 mM
glutathione ethyl ester (GEE), or transfected with the
plasmids containing the sequence encoding for catalase (pZeo-CAT), GPX
(pZeo-GPX), and Mn-SOD (pcDNA3-SOD), starting at the time when both
cell types were co-incubated. Controls included nontreated cells as
well as transfections with the empty vectors pZeo and pcDNA3.
Antioxidants were present in the incubation medium for 24 h, and
HSC cell lysates were collected and analyzed for collagen I expression
by Western blot. The signal was quantified by densitometric analysis,
and results are expressed as relative units of collagen I expression,
with the nontreated HSC co-cultured with the C34 cells (labeled as
"control") assigned a value of 1.
|
|
CYP2E1-derived Diffusible Mediators Increase the Rate of Synthesis
of Intracellular Collagen Type I but Do Not Affect the Turnover of the
Protein--
The results indicate that when HSC are co-cultured with
E47 cells (or when conditioned medium from E47 cells is added to the HSC), collagen I protein, but not the mRNA level, increases in a
time-dependent manner. This effect could be due to
regulation of collagen protein at different levels including 1)
increased translational efficiency of the COL1A1 and/or COL1A2 mRNA
or 2) decreased degradation of the protein. Although there were no
differences in the expression of intra- and extracellular MMP-13 or in
TIMP-1 or heat shock protein 47 (an important chaperone protein for
type I collagen synthesis) (data not shown), direct analysis of
collagen protein turnover by the co-cultures was performed. The HSC
were labeled with [35S]methionine for 24 h and
chased with unlabeled methionine for up to 12 h. Collagen I was
immunoprecipitated, and the remaining incorporated label was quantified
by SDS-PAGE and fluorography. The half-life of collagen and total
protein was calculated from the semilogaritmic plot of counts
incorporated per min versus time. At the 0-h time point,
prior to the initiation of the chase, the cpm incorporated into
collagen type I protein was 4-fold greater for the E47 co-culture,
suggestive of an increase in collagen synthesis (evaluated below).
Pulse-chase experiments revealed that the half-lives for collagen type
I protein were 3.9 h for stellate cells cultured alone, 4.1 h
for stellate cells co-incubated with C34 cells, and 4.5 h for
stellate cells co-cultured with E47 cells (Fig.
7, A and B). The
minor increase in the half-life of collagen protein in the E47 system
is likely to make only a small contribution to the overall (about
4-fold) increase in collagen protein in this co-culture. These
degradation experiments were carried out after first incubating the
stellate cells or co-culture systems for 24 h with the
EXPRE35S35S mix, followed by the chase
(i.e. after steady state levels of collagen were
synthesized). We also determined degradation of newly synthesized
collagen, incubating the stellate cells or co-cultures with the
EXPRE35S35S mix for 2 h and then chasing.
Half-lives of newly synthesized collagen type I protein were 5.4 h
for stellate cells cultured alone, 5.4 h for the C34 co-culture,
and 5.7 for the E47 co-culture (data not shown). Rates of degradation
of total HSC protein were similar for HSC cultured alone or with
C34 or E47 cells (Fig. 7C).

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 7.
CYP2E1-derived diffusable mediators do not
alter collagen I protein degradation. A, the rate of
collagen degradation was studied in HSC cultured alone or with C34 or
E47 cells after pulsing with [35S]methionine for 24 h, followed by chasing for 0, 1, 2, 4, 8, and 12 h.
Immunoprecipitation with anti-collagen I antibody, washing, and
fluorography was carried out as described under "Experimental
Procedures." Collagen levels were determined from PhosphorImager
analysis of fluorographs shown in A, whereas total protein
degradation was determined from the decline in trichloroacetic
acid-precipitable counts. B and C show the rate
of collagen and total protein degradation, respectively.
|
|
The rate of collagen protein synthesis was assessed next by
incubating with EXPRE35S35S mix for up to
12 h after a 24-h incubation of stellate cells with or without C34
or E47 cells, for comparative purposes with the rate of collagen
degradation. In initial experiments on collagen synthesis, HSC were
incubated with and without conditioned medium from confluent flasks of
C34 or E47 cells in the presence or absence of different doses of
cycloheximide (0, 25, 50, 100, and 150 µM), an inhibitor
of protein synthesis. When HSC were cultured with conditioned medium
from the E47 cells, cycloheximide blocked the increase in collagen I
protein (data not shown), suggesting that CYP2E1-metabolites increase
collagen levels through a protein synthesis-dependent
mechanism. Although these results indicate that de novo
protein synthesis is required, they do not rule out the possibility
that inhibition of synthesis of other proteins by cycloheximide could
prevent the CYP2E1-dependent increase in collagen type I;
to clarify this, a second approach was to study the rate of collagen I
protein synthesis by cell labeling and immunoprecipitation of collagen
I using an antibody that recognizes both the procollagen 1 and 2.
Synthesis of collagen type I protein increased as a function of time of
incubation with the 35S pulse with all three systems;
however, the rate of collagen synthesis was highest with the E47
co-culture at all time points studied (Fig.
8, A and B). At
12 h, there was a 4-fold increase in the rate of collagen
synthesis in the HSC/E47 co-culture compared with HSC cultured alone or
in the presence of the C34 cells (Fig. 8, A and
B). Cycloheximide blocked collagen synthesis in all systems at 2 h. Total protein synthesis by HSC was not altered by
co-culturing with E47 cells (Fig. 8C). These results suggest
that increased collagen synthesis and not changes in collagen
degradation are associated with increased collagen protein in the
presence of CYP2E1-mediated oxidative stress. Since COL1A1 or COL1A2
mRNA levels were not changed in the HSC/E47 co-culture, the
increase in collagen protein synthesis by this co-culture appears to
reflect an increase in translation of collagen mRNA by the
CYP2E1-derived diffusable mediators.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 8.
CYP2E1-derived diffusable mediators stimulate
collagen I protein synthesis. A, the rate of collagen
synthesis was determined at 0, 2, 4, 8, and 12 h by labeling with
[35S]methionine and immunoprecipitation as described
under "Experimental Procedures." A set of experiments in which
cells were incubated with 40 µM cycloheximide was
included at 2 h. B and C show the rate of
collagen and total protein synthesis, as determined by PhosphorImager
analysis of fluorographs of immunoprecipitated collagen or by counting
cell pellets after trichloroacetic acid precipitation.
|
|
Hepatocytes from Pyrazole-treated Rats Increase Collagen I Protein
Expression in Freshly Isolated HSC--
To verify the results obtained
in the T6-HSC and the HepG2 cell lines to primary HSC and intact
hepatocytes, freshly isolated HSC were co-incubated with primary
hepatocytes from either control or pyrazole-treated rats. Pyrazole
induces CYP2E1 protein expression about 3-fold in hepatocytes and
stabilizes the protein against degradation (22). Collagen I protein
levels in HSC cultured alone or with hepatocytes isolated from saline
control rats were undetectable at 2 days, whereas HSC co-cultured with
hepatocytes from pyrazole-treated rats showed an induction in collagen
type I protein levels (Fig.
9A). This increase was
prevented by added catalase and vitamin E, indicating that ROS were
involved. Importantly, the increase in collagen I protein was decreased
by the CYP2E1 inhibitors diallylsulfide and phenyl isothiocyanate (Fig.
9A). Validation that these compounds inactivate CYP2E1 is
shown by the 5-fold lower content and catalytic activity of CYP2E1 in
pyrazole hepatocytes treated with diallylsulfide (DAS) and
phenyl isothiocyanate (PICT) (Fig. 9B). Evidence
for the increase in CYP2E1 content by the pyrazole treatment at the
beginning and after 2 days in culture is shown by the 3-fold higher
level and catalytic activity of CYP2E1 in pyrazole versus
saline hepatocytes (Fig. 9B, right, Western blots
and activity data). These levels of CYP2E1 in the pyrazole hepatocytes
are about 7-fold higher than the levels of CYP2E1 in cell extracts of
the E47 cells.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 9.
Hepatocytes from pyrazole-treated rats induce
collagen I protein in primary HSC. Livers from control rats were
perfused with bacterial collagenase and Pronase to isolate primary HSC,
which were seeded and grown in 10% fetal bovine serum-MEM. Following
overnight incubation, the cells were washed, and fresh medium was
added. Rats were injected twice intraperitoneally with either saline or
pyrazole, and 24 h after the last injection the livers were
perfused with bacterial collagenase to isolate the hepatocytes, which
were immediately seeded on the inserts and placed on top of the HSC.
Some HSC were also cultured alone as controls. Where indicated, cells
were treated with 2000 units of catalase, 25 µM vitamin
E, 5 mM diallylsulfide (DAS), or 10 µM phenyl isothiocyanate (PICT). Either cell
lysate from the HSC or microsomes from the hepatocytes were collected
at 48 h of co-culture. A, Western blot for collagen
type I shows that the pyrazole-treated hepatocytes induce collagen I
protein in primary HSC at 48 h. No detectable collagen expression
was observed in HSC cultured alone or co-incubated with control
hepatocytes. B, Western blot depicting the expression of
CYP2E1 in pyrazole-treated hepatocytes treated with or without
diallylsulfide or phenyl isothiocyanate (first
three lanes). CYP2E1 protein levels in
pyrazole-treated and control rats at 0 and 48 h in culture are
shown on the right. Results are expressed as relative
densitometric units. CYP2E1 activity is expressed below the
blots as pmol/min/mg of protein of
p-nitrocatechol formed from the oxidation of
p-nitrophenol.
|
|
 |
DISCUSSION |
Although the development of liver fibrosis is a multicellular
process involving paracrine signaling between resident liver cells and
nonresident (immigrated) inflammatory cells, the central event in the
initiation of liver fibrogenesis relates to the activation of stellate
cells in the area of tissue necrosis and inflammation in which ROS play
an important role. Direct stimulation of HSC proliferation and collagen
synthesis by products generated from hepatocytes may contribute to
iron- and alcohol-related fibrosis. Production of prooxidant agents or
lipid peroxidation products in parenchymal cells can initiate a pathway
leading to an increase in collagen production by stellate cells (3, 4).
Results with the co-culture model indicate that CYP2E1-derived ROS can increase collagen protein synthesis by HSC.
To characterize the intercellular communication between the
hepatocyte and the stellate cell and to better understand the mechanisms by which oxidative stress and other mediator molecules perpetuate the fibrogenic response in stellate cells, a co-culture model containing HSC with a HepG2 cell line that overexpresses cytochrome P450 2E1 (E47 cells) or a control HepG2 cell line (C34 cells) was used. This system, with constant generation of ROS, may be
more reflective of the physiological conditions in the liver and 1)
allows identification of diffusable mediators responsible for
modulating collagen production, 2) permits evaluation of the role of
ROS in extracellular matrix production, and 3) may help to explore
molecular mechanisms underlying the increase of collagen type I protein.
The antioxidant defense of each cell type in both co-cultures was first
characterized; no changes in the activities of any of the antioxidant
enzymes or in GSH levels in the HSC were found. Except for glutathione
transferase, the activities of the other enzymes in the HSC were much
lower than those found in HepG2 cells, indicating a low antioxidant
defense in HSC. There were increases in both intra- and extracellular
H2O2 and in the intra- and extracellular lipid
peroxidation end products in HSC co-incubated with the E47 cells. These
observations of elevated H2O2 and lipid
peroxidation levels in the HSC/E47 co-culture suggest that ROS produced
by CYP2E1 metabolism in the HepG2 cells may diffuse and enter the HSC,
with a subsequent modulation of HSC function such as increased collagen type I protein.
In the absence of an inflammatory response, CCl4 treatment
of hepatocyte/stellate cell co-cultures increases lipid peroxidation and collagen gene expression in stellate cells (29). We investigated whether the co-incubation of HSC with the C34 or E47 cells could increase collagen expression in HSC. An increase in collagen production was detected in the HSC co-incubated with the E47 cells, which was
prevented by catalase and vitamin E, as well as by transfected catalase, GPX, and Mn-SOD, validating the participation of ROS in this
effect. Moreover, similar results were observed in freshly isolated HSC
co-incubated with hepatocytes from pyrazole-treated rats with high
CYP2E1 induction. The increase in collagen protein by the HSC/E47
co-culture was not associated with an increase in COL1A1 or COL1A2
mRNA levels. Previously, a HSC line that overexpresses CYP2E1 was
established; COL1A2 mRNA levels were elevated as compared with
empty vector-transfected HSC. The increase in COL1A2 mRNA was
blocked by antioxidants and was associated with increased transcription
of the COL1A2 gene (15, 16). In contrast, in the co-culture model,
increases in collagen protein were not associated with elevated
collagen mRNA. This may reflect 1) different effects of
intracellularly generated ROS versus extracellularly
diffusable ROS, 2) differences in the levels of ROS in the HSC
containing overexpressed CYP2E1 versus those diffusing from
the HepG2 cells through the insert to the HSC, and 3) possible
paracrine effects by other factors in the co-culture model, not present
in the HSC-CYP2E1 model.
The prevention by antioxidants of the increase in collagen protein
indicates that ROS play an important role in the
CYP2E1-dependent up-regulation. However, it is not clear
whether ROS are directly responsible for the increased collagen type I
protein synthesis or if they act to modulate other proteins or
signaling pathways, which subsequently result in an increase in
collagen synthesis. Since the only major difference between the E47 and
C34 cells is the expression of CYP2E1, the differences in ROS
production and collagen expression between the HSC/C34 and HSC/E47
co-cultures is probably due to CYP2E1. This was validated by showing
that a CYP2E1 inhibitor, diallylsulfide, prevented the increase in collagen by the HSC/E47 co-culture. A different cytochrome P450, CYP3A4
could not mimic the stimulatory effects found with the CYP2E1-expressing cells. Pyrazole hepatocytes with high levels of
CYP2E1 were more effective than saline hepatocytes in elevating collagen I protein levels. Specificity for CYP2E1, however, requires evaluation of other P450 enzymes (e.g. CYP4A10 and CYP4A14,
which were recently found to be potent generators of ROS in CYP2E1
knockout mice (30)).
Since the mechanism by which ROS increased collagen protein expression
in HSC co-cultured with E47 cells did not involve changes at the
mRNA level, the stability of collagen type I protein was studied.
Results indicated that although the rate of collagen type I protein
degradation is important for extracellular matrix remodeling in this
co-culture model, only slight differences in the half-life of
the collagen type I protein (as well as in the rate of total HSC
protein degradation) were observed; therefore, collagen accumulation,
as a consequence of decreased turnover, accounts minimally for the
differences in collagen protein observed in the E47 co-culture. These
results are in agreement with the fact that no differences were
observed in the expression of MMP-13 or TIMP-1, proteins that regulate
degradation of both normal and fibrotic liver matrix. Since it is
believed that collagen degradation lags behind collagen synthesis, it
follows that degradation is a posttranslational rather than a
co-translational process, and the fact that degradation and secretion
are kinetically distinguishable suggests that these processes may occur
in parallel pathways (31).
To explain why collagen protein was elevated in the HSC/E47 co-culture
in the absence of major changes in collagen mRNA or turnover,
experiments were carried out to determine whether these differences
were due to a more efficient translation of the collagen type I
mRNAs. The rate of collagen type I synthesis was similar between
HSC alone or cultured with the C34 cells, but a 4-fold increase in
synthesis was found in HSC cultured with the E47 cells This extent of
increase in synthesis is similar to the increases in collagen levels
observed by Western blot analysis (Fig. 4). Some specificity for the
increase in collagen synthesis is apparent from the lack of effect on
several other HSC proteins, such as catalase, MMP-13, and TIMP-1, and
the lack of effect of the HSC/E47 co-culture on total protein synthesis
by HSC. These results suggest that increased translation of collagen
mRNA was mainly responsible for the increase in collagen protein
produced by the E47 co-culture. This is, however, to our knowledge, the
first evidence that increased translation of collagen mRNA in HSC
may occur by a ROS-dependent mechanism. There are several
reports in the literature about possible mechanisms of regulation of
translation of collagen mRNA. De Crombrugghe and Schmidt (32) found
a sequence of about 50 nucleotides surrounding the translation
initiation codon remarkably conserved in the 1(I) and 2(I)
procollagen mRNAs; this sequence plays a role in determining the
level of expression of these genes by modulating translational efficiency. Kirk et al. (33) have shown that there are
pauses in the translation of procollagen -chains in intact cells.
The association of completely elongated but only partially modified procollagen chains with the polysome complex facilitates the
carboxyl-terminal interactions that lead to triple helix formation.
Veis and Kirk (34) observed that polysome-bound nascent procollagen
contains chymotrypsin, chymotrypsin plus trypsin, and pepsin-resistant -chain size components. Rossi and de Crombrugghe (35) speculated that translational efficiency of both 1(I) and 2(I) collagen mRNA could be modulated by influencing the equilibrium between monomer and dimer. Guta et al. (36) have shown that while
synthesis of pro- 1(I) and pro- 2(I) collagen chains proceeds in
parallel within the same endoplasmic reticulum compartments, their
elongation rates are not coordinated. Whether oxidative stress directly
or indirectly could affect the formation of the translational
initiation codon for collagen or export of the peptides into the
endoplasmic reticulum, the elongation rates, or the folding and
formation of the triple helix, still remains to be elucidated.
It is of interest that while changes in collagen protein by
ROS-dependent mechanisms can be associated with
transcriptional activation of the collagen genes, other possibilities,
including stability of collagen mRNA (37, 38) and increased
translational efficiency of collagen mRNA may be important for
further evaluation. The co-culture models described in this report may
be useful in furthering our understanding of intercellular
communication between hepatocytes and stellate cells and the impact of
CYP2E1-derived ROS on HSC function, activation, and collagen metabolism.
 |
ACKNOWLEDGEMENTS |
We thank Dr. Dennis Feierman for providing
the HepG2 cell lines expressing CYP3A4, Dr. Detlef Schuppan for
generous provision of polyclonal antibody raised against collagen type
I protein, Dr. John Jeffrey for the MMP-13 antibody, Dr. Marcos Rojkind
for the TIMP-1 cDNA probe, and Dr. Jerome Lasker for the CYP2E1 antibody.
 |
FOOTNOTES |
*
These studies were supported by United States Public Health
Service Grants AA03312 and AA06610 from the National Institute on
Alcohol Abuse and Alcoholism (to A. I. C.), DK 37340 from NIDDK, National Institutes of Health (to S. L. F.), and the Revson
Fellowship and a Grant from the Alcohol Beverage Medical Research
Foundation (to N. N.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Dept. of
Pharmacology and Biological Chemistry, Mount Sinai School of Medicine, Box 1603, One Gustave L. Levy Pl., New York, NY 10029. Tel.:
212-241-7285; Fax: 212-996-7214; E-mail:
arthur.cederbaum@mssm.edu.
Published, JBC Papers in Press, January 8, 2002, DOI 10.1074/jbc.M110506200
 |
ABBREVIATIONS |
The abbreviations used are:
HSC, hepatic
stellate cell(s);
COL1A1, 1 collagen type I;
COL1A2, 2 collagen
type I;
CYP2E1, cytochrome P450 2E1;
GPX, glutathione
peroxidase;
MMP, metalloproteinase;
SOD, superoxide dismutase;
ROS, reactive oxygen species;
TBARS, thiobarbituric acid-reactive
substances;
TIMP, tissue inhibitor of metalloproteinase;
MEM, minimal
essential medium.
 |
REFERENCES |
| 1.
|
Arthur, M. J. P.
(2000)
Am. J. Physiol.
279,
G245-G249
|
| 2.
|
Gualdi, R.,
Casalgrandi, G.,
Montosi, G.,
Ventura, E.,
and Pietrangelo, A.
(1994)
Gastroenterology
107,
1118-1124[Medline]
[Order article via Infotrieve]
|
| 3.
|
Pietrangelo, A.,
Gualdi, R.,
Casalgrandi, G.,
Geerts, A., De,
Blesser, P.,
Montosi, G.,
and Ventura, E.
(1994)
Hepatology
19,
714-721[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Niemela, O.,
Parkkila, S.,
Yla-Herttuala, S.,
Villanueva, J.,
Ruebner, B.,
and Halsted, C. H.
(1995)
Hepatology
22,
1208-1214[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Kamimura, S.,
Gaal, K.,
Britton, R. S.,
Bacon, B. R.,
Triadafilopoulos, G.,
and Tsukamoto, H.
(1992)
Hepatology
16,
448-453[Medline]
[Order article via Infotrieve]
|
| 6.
|
Castillo, T.,
Koop, D. R.,
Kamimura, S.,
Triadafilopoulos, G.,
and Tsukamoto, H.
(1992)
Hepatology
16,
992-996[Medline]
[Order article via Infotrieve]
|
| 7.
|
Farinati, F.,
Cardin, R.,
D'Errico, A., De,
Maria, N.,
Naccarato, R.,
Cecchetto, A.,
and Grigioni, W.
(1996)
Hepatology
23,
1468-1475[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Svegliati-Baroni, G.,
D'Ambrosio, L.,
Ferreti, G.,
Casini, A., Di,
Sario, A.,
Salzano, R.,
Ridolfi, F.,
Saccomanno, S.,
Jezequel, A. M.,
and Benedetti, A.
(1998)
Hepatology
27,
720-726[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Friedman, S. L.
(2000)
J. Biol. Chem.
275,
2247-2250[Free Full Text]
|
| 10.
|
Houglum, K.,
Filip, M.,
Witztum, J. L.,
and Chojkier, M.
(1990)
J. Clin. Invest.
86,
1991-1998[Medline]
[Order article via Infotrieve]
|
| 11.
|
Montosi, G.,
Garuti, C.,
Gualdi, R.,
Ventura, E.,
and Pietrangelo, A.
(1996)
J. Hepatol.
25,
74[CrossRef]
|
| 12.
|
Tsukamoto, H.,
Matsuoka, M.,
and French, S. W.
(1990)
Semin. Liver Dis.
10,
56-65[Medline]
[Order article via Infotrieve]
|
| 13.
|
French, S. W.
(1993)
Alcohol and Alcoholism
28,
97-109[Abstract/Free Full Text]
|
| 14.
|
Morimoto, M.,
Reitz, R. C.,
Morin, R. J.,
Nguyen, K.,
Ingelman-Sundberg, M.,
and French, S. W.
(1995)
J. Nutr.
125,
2953-2964[Abstract/Free Full Text]
|
| 15.
|
Nieto, N.,
Friedman, S. L.,
Greenwel, P.,
and Cederbaum, A. I.
(1999)
Hepatology
30,
987-996[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Nieto, N.,
Greenwel, P.,
Friedman, S. L.,
and Cederbaum, A. I.
(2000)
J. Biol. Chem.
275,
20136-20145[Abstract/Free Full Text]
|
| 17.
|
Chen, Q.,
and Cederbaum, A. I.
(1998)
Mol. Pharmacol.
53,
638-648[Abstract/Free Full Text]
|
| 18.
|
Wu, D.,
and Cederbaum, A. I.
(2001)
Mol. Pharmacol.
59,
795-805[Abstract/Free Full Text]
|
| 19.
|
Kim, Y.,
Ratziu, V.,
Choi, S. G.,
Lalazar, A.,
Theiss, G.,
Dang, Q.,
Kim, S. J.,
and Friedman, S. L.
(1998)
J. Biol. Chem.
273,
33750-33758[Abstract/Free Full Text]
|
| 20.
|
Vogel, S.,
Piantedosi, R.,
Frank, J.,
Lalazar, A.,
Rockey, D. C.,
Friedman, S. L.,
and Blaner, W. S.
(2000)
J. Lipid Res.
41,
882-893[Abstract/Free Full Text]
|
| 21.
|
Reinke, L. A.,
and Moyer, M. J.
(1985)
Drug Metab. Dispos.
13,
548-552[Abstract]
|
| 22.
|
Wu, D.,
and Cederbaum, A. I.
(1993)
J. Pharmacol. Exp. Ther.
264,
1468-1473[Abstract/Free Full Text]
|
| 23.
|
Nieto, N.,
Dominguez-Rosales, J. A.,
Fontana, L.,
Salazar, A.,
Armendariz-Borunda, J.,
Greenwel, P.,
and Rojkind, M.
(2001)
Hepatology
33,
597-607[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Fontana, L.,
Jerez, D.,
Rojas-Valencia, L.,
Solis-Herruzo, J. A.,
Greenwel, P.,
and Rojkind, M.
(1997)
Biochim. Biophys. Acta
1362,
135-144[Medline]
[Order article via Infotrieve]
|
| 25.
|
Deiana, L.,
Carru, C.,
Pes, G.,
and Tadolini, B.
(1999)
Free Radic. Res.
31,
237-244[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Fraga, C. G.,
Leibovitz, B. E.,
and Tappel, A. L.
(1987)
Free Radic. Biol. Med.
3,
119-123[Medline]
[Order article via Infotrieve]
|
| 27.
|
Myers, J. C.,
Dickson, L. A.,
de Wet, W. J.,
Bernard, M. P.,
Chu, M. L., Di,
Liberto, M.,
Pepe, G.,
Sangiorgi, F. O.,
and Ramirez, F.
(1983)
J. Biol. Chem.
258,
10128-10135[Abstract/Free Full Text]
|
| 28.
|
Mari, M.,
and Cederbaum, A. I.
(2001)
Hepatology
33,
652-661[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Bedossa, P.,
Houglum, K.,
and Trautwein, C.
(1994)
Hepatology
19,
1262-1271[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Leclercq, I. A.,
Farrell, G. C.,
Field, J.,
Bell, D. R.,
Gonzalez, F. J.,
and Robertson, G. R.
(2000)
J. Clin. Invest.
105,
1067-1075[Medline]
[Order article via Infotrieve]
|
| 31.
|
Neblock, D. S.,
and Berg, R. A.
(1986)
Biochemistry
25,
6208-6213[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
De Crombrugghe, B.,
and Schmidt, A.
(1987)
Methods Enzymol.
144,
61-74[Medline]
[Order article via Infotrieve]
|
| 33.
|
Kirk, T. Z.,
Evans, J. S.,
and Veis, A.
(1987)
J. Biol. Chem.
262,
5540-5545[Abstract/Free Full Text]
|
| 34.
|
Veis, A.,
and Kirk, T. Z.
(1989)
J. Biol. Chem.
264,
3884-3889[Abstract/Free Full Text]
|
| 35.
|
Rossi, P.,
and de Crombrugghe, B.
(1987)
Nucleic Acids Res.
15,
8935-8956[Abstract/Free Full Text]
|
| 36.
|
Guta, T., Hu, G.,
and Veis, A.
(1996)
J. Cell. Biochem.
61,
194-215[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Stefanovic, B.,
Hellerbrand, C.,
and Brenner, D. A.
(1999)
Mol. Cell. Biol.
19,
4334-4342[Abstract/Free Full Text]
|
| 38.
|
Stefanovic, B.,
Lindquist, J.,
and Brenner, D. A.
(2000)
Nucleic Acids Res.
28,
641-647[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. D. DeLeve, X. Wang, G. C. Kanel, R. D. Atkinson, and R. S. McCuskey
Prevention of Hepatic Fibrosis in a Murine Model of Metabolic Syndrome with Nonalcoholic Steatohepatitis
Am. J. Pathol.,
October 1, 2008;
173(4):
993 - 1001.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Dostalek, K. D. Hardy, G. L. Milne, J. D. Morrow, C. Chen, F. J. Gonzalez, J. Gu, X. Ding, D. A. Johnson, J. A. Johnson, et al.
Development of Oxidative Stress by Cytochrome P450 Induction in Rodents Is Selective for Barbiturates and Related to Loss of Pyridine Nucleotide-dependent Protective Systems
J. Biol. Chem.,
June 20, 2008;
283(25):
17147 - 17157.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. Friedman
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Physiol Rev,
January 1, 2008;
88(1):
125 - 172.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. G. Lechuga, Z. H. Hernandez-Nazara, E. Hernandez, M. Bustamante, G. Desierto, A. Cotty, N. Dharker, M. Choe, and M. Rojkind
PI3K is involved in PDGF-beta receptor upregulation post-PDGF-BB treatment in mouse HSC
Am J Physiol Gastrointest Liver Physiol,
December 1, 2006;
291(6):
G1051 - G1061.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Y. Chang, C.-Y. Han, T. N. Wight, and A. Chait
Antioxidants Inhibit the Ability of Lysophosphatidylcholine to Regulate Proteoglycan Synthesis
Arterioscler. Thromb. Vasc. Biol.,
March 1, 2006;
26(3):
494 - 500.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Schmidt, F. Gerlach, A. Avivi, T. Laufs, S. Wystub, J. C. Simpson, E. Nevo, S. Saaler-Reinhardt, S. Reuss, T. Hankeln, et al.
Cytoglobin Is a Respiratory Protein in Connective Tissue and Neurons, Which Is Up-regulated by Hypoxia
J. Biol. Chem.,
February 27, 2004;
279(9):
8063 - 8069.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. F. Schwabe, R. Bataller, and D. A. Brenner
Human hepatic stellate cells express CCR5 and RANTES to induce proliferation and migration
Am J Physiol Gastrointest Liver Physiol,
November 1, 2003;
285(5):
G949 - G958.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-W. Chow, M. T. Herrera Abreu, T. Suzuki, and G. P. Downey
Oxidative Stress and Acute Lung Injury
Am. J. Respir. Cell Mol. Biol.,
October 1, 2003;
29(4):
427 - 431.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Nieto and A. I. Cederbaum
Increased Sp1-dependent Transactivation of the LAMgamma 1 Promoter in Hepatic Stellate Cells Co-cultured with HepG2 Cells Overexpressing Cytochrome P450 2E1
J. Biol. Chem.,
April 18, 2003;
278(17):
15360 - 15372.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. C. Chung, S. H. Kim, M. G. Lee, and S. G. Kim
Increase in Urea in Conjunction with L-Arginine Metabolism in the Liver Leads to Induction of Cytochrome P450 2E1 (CYP2E1): The Role of Urea in CYP2E1 Induction by Acute Renal Failure
Drug Metab. Dispos.,
June 1, 2002;
30(6):
739 - 746.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|